Abstract:Objective: To study the clinical effect of conjoint fascial sheath (CFS) suspension and levator palpebrae superioris muscle shortening in the treatment of severe blepharoptosis. Methods: Forty-five patients with severe blepharoptosis (75 eyes) from May 2020 to February 2022 in the authors' hospital were divided into 2 groups: group A (n = 33, 43 eyes) and group B (n = 24, 32 eyes). Group A was operated on by CFS + levator muscle shortening, and group B was operated on by frontal muscle flap suspension + levator muscle shortening. Both groups were followed up for 12 months (until February 2023). The clinical effect was counted in 6 months after operation, the early complications were counted in 1 month after operation, and the late complications were counted in 1 month to 12 months after operation. Margin to corneal reflex distance 1 (MRD1) and palpebral fissure height (PFH) were recorded before, 1 week, 3 months, and 12 months postoperatively, and the amount of eyelid retrogression was counted again. Results: The good correction rate was 90.70% in group A, higher than in group B (71.88%), and the difference was statistically significant ( P < 0.05); the early postoperative complication rate was 9.30%, lower than in group B (24.38%), and the difference was statistically significant ( P < 0.05); the late postoperative complication rate was 2.33%, lower than group B (18.75%), and the difference was statistically significant ( P < 0.05). The MRD1 and PFH of group A were higher than those of group B ( P < 0.05) at 3 months postoperatively and 12 months postoperatively; the MRD1 and PFH of group A were lower than those of group B ( P < 0.05) at 3 months postoperatively and 12 months postoperatively. Repeated measurement analysis of variance showed that there were significant differences in the main effects of MRD1, PFH, eyelid retrogression, and time in group A and group B ( P < 0.05), and there was interaction between intervention and time ( P < 0.05). Conclusion: Conjoint fascial sheath suspension combined with levator palpebrae superioris muscle shortening can effectively improve MRD1 and PFH, and the amount of upper eyelid retraction is controllable 1 year after operation.

Corticosteroid eyedrops induced blepharoptosis and atrophy of levator muscle

Clinical Effect of Combined Fascia Sheath Suspension With Shortening Levator Muscle on Severe Blepharoptosis

One Patient of Blepharoptosis Caused by Levator Palpebrae Superioris Aponeurosis Degeneration

Changes of Corneal Tomography in Patients with Congenital Blepharoptosis

Analysis and Treatment of an Acquired Blepharoptosis after Blepharoplasty

Quantitative Evaluation of the Effects of Blepharoplasty on Visual Field, Corneal Changes, and Cosmetic Appearance

The Prevalence and Severity of Acquired Blepharoptosis in US Eye Care Clinic Patients and Their Receptivity to Treatment

The effect of ptosis surgery on corneal topography and aberrometry

Effect of upper eyelid blepharoplasty on the ocular surface, tear film, and corneal microstructure

Postoperative levator function change in patients with unilateral myogenic versus aponeurotic blepharoptosis

The Long-Term Effect on Dry Eye of Posterior Approach Ptosis Surgery Vs. Upper Eyelid Blepharoplasty

Significant Changes of Corneal Astigmatism After Levator Muscle Surgery for Acquired Blepharoptosis

Relative incidence of blepharoptosis subtypes in an oculoplastics practice at a tertiary care center

Symmetry of upper eyelid after unilateral blepharoptosis repair with minimally invasive conjoint fascial sheath suspension technique

A multicenter, randomized, parallel-group, clinical trial comparing the safety and efficacy of loteprednol etabonate 0.5%/tobramycin 0.3% with dexamethasone 0.1%/tobramycin 0.3% in the treatment of Chinese patients with blepharokeratoconjunctivitis.

A Clinical Study of the Efficacy of Topical Corticosteroids on Dry Eye

Conjunctival Chalasis Should Not be Overlooked: Investigation Into Postoperative Ocular Surface Changes in Involutional Blepharoptosis

Anatomic and Magnetic Resonance Imaging-Based Correction of Upper-Eyelid Depression and Blepharoptosis in Senile Patients

Ocular surface parameter changes in the untreated fellow eye after unilateral cataract surgery with short-term administration of anti-inflammatory eye drops

Modified Conjoint Fascial Sheath and Levator Muscle Complex Suspension for the Correction of Simple Severe Congenital Ptosis in Pediatrics and the Effect on Refractive Status

Release of fibrous web bands between the preaponeurotic fat pad and Levator aponeurosis in subclinical blepharoptosis correction during double‐eyelid blepharoplasty